Lungs are a major organ site of cytomegalovirus latency and recurrence - PubMed (original) (raw)
Lungs are a major organ site of cytomegalovirus latency and recurrence
M Balthesen et al. J Virol. 1993 Sep.
Abstract
Recurrence of infectious virus from the latent viral genomes is the initiating event in the pathogenesis of cytomegalovirus (CMV) disease during states of immunodeficiency. Interstitial pneumonia is a frequent manifestation of posttransplantation CMV disease, in particular after bone marrow transplantation and heart and lung transplantations. Recurrence can occur within the transplant derived from a latent infected donor as well as within latently infected organs of the transplant recipient. The reason for a predilection of the lungs as a site of CMV pathology is so far unknown. In a murine model of CMV latency, the lungs were identified as an authentic site of latent infection, since the viral genome remained detectable in lung tissue even after it was cleared to an undetectable level in blood and bone marrow. A comparison between the lungs and the spleen, the previously most thoroughly investigated site of murine CMV latency, revealed a 10-fold-higher burden of latent viral genome for the lungs. Most important, the organ-specific risk of in vivo recurrence was found to correlate with the organ-specific viral genomic load. This new finding thus characterizes the lungs as a high-risk organ for CMV recurrence, and this fact may explain in part why interstitial pneumonia is a frequent manifestation of recurrent CMV infection.
Similar articles
- The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.
Balthesen M, Dreher L, Lucin P, Reddehase MJ. Balthesen M, et al. J Gen Virol. 1994 Sep;75 ( Pt 9):2329-36. doi: 10.1099/0022-1317-75-9-2329. J Gen Virol. 1994. PMID: 8077931 - The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
Reddehase MJ, Balthesen M, Rapp M, Jonjić S, Pavić I, Koszinowski UH. Reddehase MJ, et al. J Exp Med. 1994 Jan 1;179(1):185-93. doi: 10.1084/jem.179.1.185. J Exp Med. 1994. PMID: 8270864 Free PMC article. - Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.
Steffens HP, Kurz S, Holtappels R, Reddehase MJ. Steffens HP, et al. J Virol. 1998 Mar;72(3):1797-804. doi: 10.1128/JVI.72.3.1797-1804.1998. J Virol. 1998. PMID: 9499030 Free PMC article. - Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors.
Kondo K, Mocarski ES. Kondo K, et al. Scand J Infect Dis Suppl. 1995;99:63-7. Scand J Infect Dis Suppl. 1995. PMID: 8668945 Review. - Latent infection and the elusive cytomegalovirus.
Jordan MC. Jordan MC. Rev Infect Dis. 1983 Mar-Apr;5(2):205-15. doi: 10.1093/clinids/5.2.205. Rev Infect Dis. 1983. PMID: 6302813 Review.
Cited by
- QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection.
Solidoro P, Sciarrone F, Sidoti F, Patrucco F, Zanotto E, Boffini M, Rinaldo RF, Bondi A, Albera C, Curtoni A, Costa C. Solidoro P, et al. Viruses. 2024 Aug 4;16(8):1251. doi: 10.3390/v16081251. Viruses. 2024. PMID: 39205225 Free PMC article. - Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword.
Bharti R, Calabrese DR. Bharti R, et al. Front Transplant. 2024 Jun 10;3:1388393. doi: 10.3389/frtra.2024.1388393. eCollection 2024. Front Transplant. 2024. PMID: 38993763 Free PMC article. Review. - Immunosenescence and Cytomegalovirus: Exploring Their Connection in the Context of Aging, Health, and Disease.
Müller L, Di Benedetto S. Müller L, et al. Int J Mol Sci. 2024 Jan 6;25(2):753. doi: 10.3390/ijms25020753. Int J Mol Sci. 2024. PMID: 38255826 Free PMC article. Review. - The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors.
Kamel MS, Munds RA, Verma MS. Kamel MS, et al. Int J Mol Sci. 2023 Nov 9;24(22):16112. doi: 10.3390/ijms242216112. Int J Mol Sci. 2023. PMID: 38003300 Free PMC article. Review. - Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion.
Ribeiro RVP, Samman A, Wang A, Wang S, Martinu T, Keshavjee S, Singer LG, Kumar D, Humar A, Cypel M. Ribeiro RVP, et al. JTCVS Open. 2023 Feb 22;14:590-601. doi: 10.1016/j.xjon.2023.02.008. eCollection 2023 Jun. JTCVS Open. 2023. PMID: 37425481 Free PMC article.
References
- Annu Rev Microbiol. 1987;41:543-71 - PubMed
- J Virol. 1987 Jun;61(6):1901-8 - PubMed
- J Virol. 1988 Mar;62(3):987-97 - PubMed
- Science. 1988 Jan 29;239(4839):487-91 - PubMed
- Nature. 1989 May 18;339(6221):237-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical